pyrroles has been researched along with 4-hydroxyatorvastatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantola, T; Kivistö, KT; Neuvonen, PJ | 1 |
| Benet, LZ; Frassetto, L; Huang, Y; Lau, YY | 1 |
| Chaikin, P; Dvorchik, B; Mori, A; Rao, N; Sussman, N; Uchimura, T; Wang, H; Yamamoto, K | 1 |
| Abel, R; Alvey, C; Bullen, W; Hartman, D; Porcari, AR; Whitfield, LR | 1 |
| Chakraborty, BS; Gaur, S; Ghosh, C; Jain, I; Patel, N; Upadhyay, A | 1 |
| Buianova, SV; Korobov, GD; Osochuk, SS | 1 |
| El-Tahtawy, A; Gandelman, K; Gastonguay, MR; Jen, F; Knebel, W; Malhotra, B | 1 |
5 trial(s) available for pyrroles and 4-hydroxyatorvastatin
| Article | Year |
|---|---|
Effect of itraconazole on the pharmacokinetics of atorvastatin.
Topics: Adult; Anticholesteremic Agents; Antifungal Agents; Area Under Curve; Atorvastatin; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Male; Pyrroles; Smoking | 1998 |
effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Atorvastatin; Bile; Binding, Competitive; Biological Transport; Cell Line; Cross-Over Studies; Enzyme Inhibitors; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intravenous; Liver; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Organic Anion Transporters; Pyrroles; Rifampin; Substrate Specificity; Tablets; Transfection | 2007 |
A study of the pharmacokinetic interaction of istradefylline, a novel therapeutic for Parkinson's disease, and atorvastatin.
Topics: Administration, Oral; Antiparkinson Agents; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Purines; Pyrroles | 2008 |
Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin.
Topics: Adult; Atorvastatin; Biotransformation; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Female; Fenofibrate; Gemfibrozil; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lactones; Male; Middle Aged; Pyrroles | 2011 |
Population pharmacokinetics of atorvastatin and its active metabolites in children and adolescents with heterozygous familial hypercholesterolemia: selective use of informative prior distributions from adults.
Topics: Adolescent; Adult; Atorvastatin; Child; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Models, Biological; Pyrroles | 2013 |
2 other study(ies) available for pyrroles and 4-hydroxyatorvastatin
| Article | Year |
|---|---|
Simultaneous estimation of atorvastatin and its two metabolites from human plasma by ESI-LC-MS/MS.
Topics: Atorvastatin; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Heptanoic Acids; Humans; Molecular Structure; Pyrroles; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency | 2011 |
[The composition of blood lipoproteins of donors 2 hours later after single atorvastatin intake].
Topics: Anticholesteremic Agents; Atorvastatin; Biological Transport, Active; Female; Heptanoic Acids; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Pyrroles; Sex Characteristics; Time Factors | 2011 |